x
Diabetes, Obesity & Metabolic Disorders Open Access ISSN : 2456-3765
Statistics of diabetes in world
  • Krishna

    Krishna, Department of Medicine, Mamatha medical college, India. Email: krishna@gmail.com

Received: 20-09-2019

Accepted: 18-11-2019

Published: 20-11-2019

Citation: Allen Burner (2019) Diabetics statistics in different country, Diab Obes Metab Disor OA 5: 5-9

Copyrights: 2019, Allen Burner

Introduction

Diabetes is a chronic, metabolic disease characterized by elevated levels of blood sugar, which leads to serious damage to the heart, blood vessels, eyes, kidneys and nerves. The most common type is type 2 diabetes, which occurs when the body becomes resistant to insulin or doesn't make enough insulin. In the past three decades the prevalence of type 2 diabetes has raised dramatically in the countries of all income levels. Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin by itself. For people living with diabetes, access to affordable treatment, including insulin, is critical to their survival.

 

The globally agreed target to halt the rise in diabetes and obesity by 2025.

 

About 422 million people worldwide have diabetes, the majority living in low-and middle-income countries, and 1.6 million deaths are directly attributed to diabetes each year. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades [1].

 

Diabetes is on the rise across the globe, presently every seven seconds someone is estimated to die from diabetes or its complications, Moreover, it was estimated that the number of adults with diabetes in the world had increased from 108 million in 1980 to 422 million in 2014, Besides the growth and aging of the world population in general, the global obesity epidemic has turned out to be a key factor for the rise of diabetes incidence together with the immense progress of multifactorial cardiovascular risk management and successful revascularization therapy of people with diabetes also contributing to the expansion of the worldwide diabetes population[2].

 

Diabetes more or less equally affects both sexes with men having a small edge over women at younger age groups and women surpassing men at higher age groups.

 

Depending on age groups, global diabetes prevalence is about 5% for the age group 35-39 years, 10% for the age group 45-49 years, 15% for the age group 55-59 years, and close to 20% starting at age group 65-69 years.  Diabetes prevalence numbers are largely determined by people with type2 diabetes who comprise about 90% of the total population. These individuals are characterized by various degrees of relative insulin deficiency in conjunction with a wide spectrum of insulin resistance [2-22].

Statistics

Country

2000

2030

Afghanistan

468000

1403000

Algeria

426000

1203000

Angola

51000

140000

Antigua and Barbuda

3000

5000

Argentina

1426000

2457000

Australia

941000

1673000

Bahamas

12000

26000

Bahrain

37000

99000

Bangladesh

3196000

11140000

Barbados

11000

22000

Belize

5000

15000

Benin

87000

266000

Bhutan

35000

109000

Bolivia

207000

562000

Botswana

25000

45000

Brazil

4553000

11305000

Brunei Darussalam

18000

49000

Burkina Faso

124000

388000

Burundi

26000

72000

Cambodia

110000

317000

Cameroon

70000

171000

Canada

2006000

3543000

Cape Verde

7000

24000

Central African Republic

18000

38000

Chad

97000

269000

Chile

495000

1047000

China

20757000

42321000

Colombia

883000

2425000

Comoros

4000

15000

Congo

14000

39000

Cook Islands

700

1300

Costa Rica

76000

237000

Côte d'Ivoire

264000

636000

Cuba

480000

855000

Cyprus

50000

87000

Dem. People's Rep. of Korea

367000

635000

Democratic Republic of the Congo

291000

910000

Djibouti

7000

9000

Dominica

3000

4000

Dominican Republic

245000

594000

Ecuador

341000

921000

Egypt

2623000

6726000

El Salvador

103000

320000

Equatorial Guinea

8000

21000

Eritrea

47000

142000

Ethiopia

796000

1820000

Federated States of Micronesia

5000

13000

Fiji

37000

72000

Gabon

8000

14000

Gambia

22000

61000

Ghana

302000

851000

Grenada

4000

7000

Guatemala

139000

447000

Guinea

34000

89000

Guinea-Bissau

17000

44000

Guyana

19000

36000

Haiti

161000

401000

Honduras

81000

269000

India

31705000

79441000

Indonesia

8426000

21257000

Iraq

668000

2009000

Islamic Republic of Iran

2103000

6421000

Jamaica

81000

189000

Japan

6765000

8914000

Jordan

195000

680000

Kenya

183000

498000

Kiribati

4000

7000

Kuwait

104000

319000

Lao People's Dem. Rep.

46000

128000

Lebanon

146000

378000

Lesotho

31000

42000

Liberia

40000

154000

Libyan Arab Jamahiriya

88000

245000

Madagascar

100000

301000

Malawi

55000

118000

Malaysia

942000

2479000

Maldives

6000

25000

Mali

140000

405000

Marshall Islands

2000

4000

Mauritania

34000

103000

Mauritius

111000

233000

Mexico

2179000

6130000

Mongolia

34000

81000

Morocco

427000

1138000

Mozambique

133000

273000

Myanmar

543000

1330000

Namibia

25000

60000

Nauru

2000

4000

Nepal

436000

1328000

New Zealand

179000

307000

Nicaragua

68000

246000

Niger

108000

382000

Nigeria

1707000

4835000

Niue

<> 

<> 

Oman

113000

343000

Pakistan

5217000

13853000

Palau

1000

2000

Panama

59000

155000

Papua New Guinea

152000

392000

Paraguay

102000

324000

Peru

754000

1961000

Philippines

2770000

7798000

Qatar

38000

88000

Republic of Korea

1859000

3378000

Rwanda

30000

77000

Saint Kitts and Nevis

2000

2000

Saint Lucia

5000

11000

Saint Vincent and the Grenadines

5000

9000

Samoa

4000

7000

Sao Tome-Principe

1000

2000

Saudi Arabia

890000

2523000

Senegal

143000

421000

Seychelles

8000

19000

Sierra Leone

65000

178000

Singapore

328000

695000

Solomon Islands

13000

41000

Somalia

97000

331000

South Africa

814000

1286000

Sri Lanka

653000

1537000

Sudan

447000

1277000

Suriname

9000

20000

Swaziland

13000

21000

Syrian Arab Republic

627000

2313000

Thailand

1536000

2739000

Togo

64000

184000

Tonga

3000

6000

Trinidad and Tobago

60000

125000

Tunisia

166000

388000

Tuvalu

300

800

Uganda

98000

328000

United Arab Emirates

350000

684000

United Republic of Tanzania

201000

605000

United States of America

17702000

30312000

Uruguay

154000

224000

Vanuatu

6000

17000

Venezuela

583000

1606000

Viet Nam

792000

2343000

Yemen

327000

1286000

Zambia

70000

186000

Zimbabwe

108000

265000

 

Table 1: Statistics of Diabetes in different countries [1]

References

  1. World health Organization

  2. Global statistics on diabetes

  3. Mahendra Kumar Sahu, Vijay Kumar Singh, S. Prakash Rao (2018) Development and Evaluation of Antidiabetic Potential of Polyherbal Formulation in Streptozotocin Induced Animal Model, Diab Obes Metab Disor OA 4: 20-30.

  4. Milind G. Ruke (2018) Management of diabetic foot and amputations due to diabetes: Role of prostheses and orthoses, Diab Obes Metab Disor OA 4: 16-19

  5. Guilford BL, Leey JA ,Strassels SA, Rai A, Herndon CM (2018) Is Impaired Hypoglycemia Awareness Associated with Obstructive Sleep Apnea in Diabetic Patients?. Diab Obes Metab Disor OA 4: 16-23.

  6. Siegel EG, Platten I, Kraft M , Lorenzo Bermejo J, Hasslacher C (2018) Composition of intestinal microbiome and barrier function in Type 2 diabetic patients and nondiabetic controls. Diab Obes Metab Disor OA 4: 10-15.

  7. Alok Raghav, Jamal Ahmad (2018) Diabetes mellitus and foot ulcer: Always challenge to society. Diab Obes Metab Disor OA 4: 5-9

  8. Francisco J. Sanchez-Muniz, Garcia Quismondo A, Del Canizo FJ (2018) C Reactive Protein And Obesity In Type 2 Diabetes Mellitus Patients From The Dicariva Study . Diab Obes Metab Disor OA 4: 1-4.

  9. Ana Paulina Barba de la Rosa, Erik Elvin Gómez-Cardona, Eric Edmundo Hernández-Domìnguez, José Ángel Huerta-Ocampo, Hugo Jiménez-Islas etal., (2017) Effect of amaranth consumption on diabetes-related biomarkers in patients with diabetes Diab Obes Metab Disor OA 3: 5-10

  10. Ying Hua Gao-Balch (2016) Nutrients with Binge Drinking in the College Students, Diab Obes Metab Disor OA 2: 47-49.

  11. DeGeeter M, Williamson BJ, Meadowcraft LM (2016) A review of the current literature and guidance for treatment of the dawn phenomenon and glycemic variability, Diab Obes Metab Disor OA 2: 100115.

  12. Khalida A (2016) Diabetes and Metabolic Disorders, a Study among Population of Adults in Tebessa (City of Eastern Algeria). Diab Obes Metab Disor OA 2: 100106.

  13. Askari G (2016) The effect of anthocyanin supplementation on systolic and diastolic blood pressure and mean arterial pressure in athletes. Diab Obes Metab Disor OA 2: 100107.

  14. Maghsoudi Z (2016) The effect of resveratrol supplementation on malondialdehyde, TNFα and interlukine-2 in elite female volleyball players. Diab Obes Metab Disor OA 2: 100108.

  15. Ghiasvand R, Maghsoudi Z, Darvishi L, Shoaei T (2016) The effect of jujube powder on several digestive symptoms and C-reactive protein in patients with irritable bowel syndrome. Diab Obes Metab Disor OA 2: 100109.

  16. Nourian M, Maghsoudi Z, Shirani F (2016) Assessment of mineral intake in Adolescent School Children of Isfahan. Diab Obes Metab Disor OA 2: 100110.

  17. Maghsoudi Z, Foroughi M, Askari G (2016) The effect of vitamin D supplementation on body composition parameters in patients with non-alcoholic fatty liver disease (NAFLD). Diab Obes Metab Disor OA 2: 100111.

  18. Kevin GC (2015) Diabetes: What the Past tells us about the Future. Diab Obes Metab Disor OA 1: 100101.

  19. Latifi SM (2015) Efficiency of Anthropometric Indices in Predicting Metabolic Syndrome among Adult Population of Ahvaz, Iran. Diab Obes Metab Disor OA 1: 100102.

  20. Dixit AK (2015) Let the Sunshine In: Therapeutic Prospects of Vitamin D in Diabetology. Diab Obes Metab Disor OA 1: 100103.

  21. Fabiane Gomes de Moraes Rego (2016) Polymorphisms in the Fat Mass and Obesity Associated (FTO) and Transcription factor 7-like 2 (TCF7L2) genes in Euro-Brazilian individuals with type 2 diabetes. Diab Obes Metab Disor OA 2: 100104.

  22. Maghsoudi Z (2016) The role of flax seed in prevention and management of diabetes mellitus type I and type II. Diab Obes Metab Disor OA 2: 100105.

 

Table of Contents
Signup to recive email updatesx